Literature DB >> 9487167

Unlicensed and off label drug use in paediatric wards: prospective study.

S Turner1, A Longworth, A J Nunn, I Choonara.   

Abstract

OBJECTIVE: To determine the extent of use in children in hospital of drugs that are not specifically licensed for use in children (unlicensed) and of drugs that are used outside the terms of their product licence that apply to indication, age, dose, or route of administration (off label).
DESIGN: Prospective study of drugs administered on paediatric medical and surgical wards for 13 weeks.
SETTING: Regional children's hospital.
SUBJECTS: Paediatric inpatients in medical and surgical wards. MAIN OUTCOME MEASURES: Comparison of the use of each drug with its product licence to determine whether the drug was used in an unlicensed or off label manner.
RESULTS: 2013 courses of drugs were administered to 609 paediatric patients in 707 admissions. 506 (25%) of the drug courses (prescriptions) were either unlicensed (139) or off label (367) uses. In 256 (36%) of the 707 admissions patients received one or more courses of an unlicensed or off label treatment in hospital.
CONCLUSIONS: Use of drugs in an off label or unlicensed manner to treat children is widespread. Drugs are more likely to be used in an off label manner than in an unlicensed manner.

Entities:  

Mesh:

Year:  1998        PMID: 9487167      PMCID: PMC2665567          DOI: 10.1136/bmj.316.7128.343

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  105 in total

1.  Status of new medicines approved by the European Medicines Evaluation Agency regarding paediatric use.

Authors:  P Impicciatore; I Choonara
Journal:  Br J Clin Pharmacol       Date:  1999-07       Impact factor: 4.335

Review 2.  Paediatric prescribing: using unlicensed drugs and medicines outside their licensed indications.

Authors:  J Collier
Journal:  Br J Clin Pharmacol       Date:  1999-07       Impact factor: 4.335

3.  A novel scheme for the reporting of adverse drug reactions.

Authors:  A Clarkson; E Ingleby; I Choonara; P Bryan; P Arlett
Journal:  Arch Dis Child       Date:  2001-04       Impact factor: 3.791

4.  Prescribing medicines for children.

Authors:  A G Sutcliffe
Journal:  BMJ       Date:  1999-07-10

Review 5.  Drug trials in children: problems and the way forward.

Authors:  S Conroy; J McIntyre; I Choonara; T Stephenson
Journal:  Br J Clin Pharmacol       Date:  2000-02       Impact factor: 4.335

6.  Unlicensed and off label prescribing of drugs in general practice.

Authors:  J McIntyre; S Conroy; A Avery; H Corns; I Choonara
Journal:  Arch Dis Child       Date:  2000-12       Impact factor: 3.791

Review 7.  Unlicensed and off-label drug use in children: implications for safety.

Authors:  Imti Choonara; Sharon Conroy
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 8.  Medicines for children--the last century and the next.

Authors:  T Stephenson
Journal:  Arch Dis Child       Date:  2001-09       Impact factor: 3.791

9.  Unlicensed and off label drug use by children in the community: cross sectional study.

Authors:  Eric Schirm; Hilde Tobi; Lolkje T W de Jong-van den Berg
Journal:  BMJ       Date:  2002-06-01

Review 10.  Developmental dysplasia of the hip (DDH): an evolving science.

Authors:  H Bauchner
Journal:  Arch Dis Child       Date:  2000-09       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.